Due to its low incidence and diverse manifestations, paradoxical embolism (PDE) is still under-reported and is not routinely considered in differential diagnoses. Concomitant acute myocardial infarction (AMI) and acute pulmonary embolism (PE) caused by PDE has rarely been reported.
Case presentation
A 45-year-old woman presented with acute chest pain and difficulty with breathing. Multiple imaging modules including ECG, echocardiography, emergency cardioangiogram (CAG), and CT angiography of the pulmonary arteries showed acute occlusion of the posterolateral artery and acute PE.
After coronary aspiration, no residual stenosis was observed. One month later, a bubble study showed inter-atrial communication via a patent foramen ovale (PFO). The AMI in this patient was finally attributed to PDE via the PFO. PFO closure was performed, and long-term anticoagulation was prescribed to prevent recurrent thromboembolic events.
Conclusions
PDE via PFO is a rare etiology of AMI, especially in patients with concomitant AMI and PE. Clinicians should be vigilant of this possibility and close the inter-atrial channel for secondary prevention.
Hinweise
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Abkürzungen
AMI
Acute myocardial infarction
PDE
Paradoxical embolism
PE
Pulmonary embolism
PFO
Patent foramen ovale
TIA
Transient ischemic attack
Background
Paradoxical embolism (PDE) was first described by the German pathologists Cohnheim et al., who found a large number of emboli in the cerebral artery in an autopsy patient, and at the same time, a long embolus in the femoral vein. PDE refers to a embolus from the vein or right heart system that passes through the right to left shunt to the left heart, resulting in systemic embolism [1]. Patent foramen ovale (PFO) is one of the inter-atrial channels that causes PDE. The brain is the organ most commonly affected by PDE, resulting in cryptogenic stroke or transient ischemic attack (TIA), followed by the limbs and internal organs, and involvement of the coronary arteries is rarely reported [2]. For management after the diagnosis of PDE, closure of PFO was recommended in selected patients to prevent further systemic embolism [3].
Acute myocardial infarction (AMI) and acute pulmonary embolism (PE) are both life-threatening diseases that initially present with acute chest pain. Clinicians should be vigilant of the possibility of coronary embolism in the differential diagnosis of acute chest pain in young patients with AMI. When acute PE exists, the acutely increased right atrial pressure reopens the closed PFO and facilitates PDE to the brain or coronary artery [4]. Here, we report the diagnosis and management of a young patient with AMI caused by PDE, and acute PE.
Anzeige
Case presentation
A 45-year-old female patient was admitted to our hospital with acute chest pain and difficulty in breathing for 2 h. Her past medical history was notable for an orthopedic surgical procedure and a confirmed pulmonary embolism, which was managed with thrombolytic therapy in the acute phase and oral anticoagulation treatment (rivaroxaban 15 mg bid for 1 month; 20 mg qd thereafter). Physical examination showed normal BP (110/64 mmHg) and rales in the lungs. On admission, she underwent an ECG (Fig. 1A), which showed ST elevation in the inferior wall leads. Bedside echocardiography demonstrated inferior wall hypokinesis and mildly increased pulmonary artery pressure (35 mmHg), with normal cardiac function (EF, 63%). Cardiac injury biomarkers were as follows: cardiac troponin I (cTnI) 0.06 ng/ml ↑, myoglobin 12.0 ug/ml ↑. Other tests showed elevated D-dimers level (2910 ng/mL ↑), and blood gas test showed decreased PO2 (55 mmHg) and normal PCO2 (26 mmHg). An emergency cardioangiogram (CAG) revealed acute occlusion of the posterolateral artery (PL) (Fig. 1B), and CTA of the pulmonary arteries revealed acute pulmonary embolism (Fig. 1C, red arrows).
×
Based on the symptoms, past medical history, CAG, and pulmonary CTA findings, the patient was diagnosed with acute inferior wall STEMI, Killip class I, acute pulmonary embolism (intermediate-risk group), and type I respiratory failure.
In consideration of the need for coronary intervention, after embolus aspiration, coronary flow returned to TIMI grade 3, and no residual stenosis or plaque remained (Fig. 2A). Intracoronary imaging was recommended to confirm the cause of the acute occlusion, but it was declined by the patient. No balloon dilation or stent implantation was performed.
×
The relationship between AMI and PE in this patient is unknown. On lower extremity vascular ultrasound, rheumatic disease-related embolism and tumor-related emboli were ruled out. Because of the concern engendered by the increase in pulmonary artery pressure, a bubble study was not recommended (owing to the risk of further increase in pulmonary artery pressure) by the echocardiologist, and paradoxical embolism could not be ruled out.
Anzeige
Triple antithrombotic therapy was recommended (aspirin, clopidogrel, and factor Xa inhibitor for one month; clopidogrel and factor Xa inhibitor until one year; factor Xa inhibitor lifelong). At the one-month follow-up, pulmonary CTA showed no residual embolism (Fig. 2C). Echocardiography revealed normal pulmonary artery pressure. A bubble study showed > 10 bubbles crossing into the LA in one cardiac cycle (Fig. 22), which was considered an echocardiographic feature of paradoxical embolism [5]. Paradoxical embolism via the interatrial channel was considered the etiology of the chest pain, and patent foramen ovale (PFO) closure was performed for this patient (Fig. 2D). Additionally, the antithrombotic strategy was changed to an anticoagulant (factor Xa inhibitor) only. Three-month and 6-month telephone follow-ups showed good recovery.
Discussion
Coronary embolism should be considered in patients with AMI, especially in patients with hypercoagulable status [6]. Due to the diverse clinical manifestations, PDE is still under-diagnosed [1]. In particular, AMI caused by PDE is rarely reported, and no large study on this special patient cohort has been conducted.
The diagnosis of PDE is mostly presumptive, except for those with evidence of emboli in-transit (called impending PDE) via PFO [7]. There are three required conditions in the diagnosis: emboli from a venous source, abnormal inter-cardiac communication (atrial septal defect or PFO), and evidence of systemic embolism [1, 8]. In this case, the patient met the three conditions, and the source of the embolism in PL was not the left ventricle or other arteries. Coronary embolism from other sources was excluded.
AMI and acute PE are both life-threatening diseases presenting with acute chest pain. Concomitant AMI and acute PE have been reported in a limited number of cases [3, 9, 10] and interestingly, PDE is the common etiology of coronary embolism. Acute PE seems to facilitate the travel of embolism via PFO to the left heart system [18]. In a prospective observational study of 139 patients with major PE, patients were at a significantly higher risk of stroke and peripheral arterial embolism in the PFO group than in patients without PFO [18]. From a pathophysiological perspective, acute PE increases right heart pressure, causes the foramen ovale to reopen, and subsequently facilitates PDE [4]. In this case, the bubble study also verified the right-to-left shunt via PFO after acute PE.
Concomitant AMI and PE are indicative of a PDE. However, the diagnosis of concomitant AMI and PE is sometimes challenging (Table 1) because the two conditions share the similar symptom of acute chest pain. For this special clinical scenario, a past history of deep vein thrombosis (DVT) or PE, or accompanying symptoms (difficulty in breathing, cough, unexplained dyspnea, or respiratory failure) is helpful for clinicians to differentiate between AMI and PE. In this case, the diagnosis was prompted by the past medical history and the accompanying symptoms.
Table 1
PDE cases reported in MEDLINE/PubMed and scopus databases
To confirm the right-to-left shunt via PFO, bubble studies (bubbles seen in the left atrium in less than three cardiac cycles) [19], and transesophageal echocardiography are usually recommended [1]. Other imaging techniques such as multi-slice computed tomography or MRI (for screening emboli -in-transit) and transcranial Doppler sonography (more specific for PDE-related stroke) can also help in the diagnosis of PDE [1].
The treatments for PDE patients vary vastly depending on the size of the embolus and the thromboembolism sites (Table 1). For the treatment of concomitant AMI and PE caused by PDE, the top priority is to evaluate the hemodynamic status and start thrombolysis if the patient is hemodynamically unstable [9]. Although embolus aspiration is not routinely recommended in AMI intervention, it is mandatory in AMI caused by PDE to eliminate the embolus and restore coronary flow. Percutaneous closure of PFO was recommended in patients aged 18 to 65 years with a highly presumed PFO-related systemic embolism [20] for prevention of a second embolic episode. Moreover, anticoagulation is recommended to prevent emboli from the venous system [20].
Conclusions
PDE via PFO is a rare etiology of AMI, especially in patients with concomitant AMI and PE. Clinicians should be vigilant of this possibility and close the inter-atrial channel for secondary prevention.
Anzeige
Acknowledgements
None.
Declarations
Ethics approval and consent to participate
The patient provided informed consent to participate.
Consent for publication
Written informed consent was obtained from the patient for the publication of this case report and any accompanying images.
Competing interests
The authors declare that they have no competing interests.
Anzeige
Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Routinemäßige Mammografien helfen, Brustkrebs frühzeitig zu erkennen. Anhand der Röntgenuntersuchung lassen sich aber auch kardiovaskuläre Risikopatientinnen identifizieren. Als zuverlässiger Anhaltspunkt gilt die Verkalkung der Brustarterien.
Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.
Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.
Der als Antidiabetikum sowie zum Gewichtsmanagement zugelassene Wirkstoff Tirzepatid hat in Studien bei adipösen Patienten auch schlafbezogene Atmungsstörungen deutlich reduziert, informiert der Hersteller in einer Vorab-Meldung zum Studienausgang.
Update Kardiologie
Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.